Washington: In a first device for quick testing of coronavirus, the Food and Drug Administration (FDA) has issued an emergency use authorisation for a device that can detect Covid virus in breath samples.
According to the authorities, InspectIR Covid-19 Breathalyzer will be used in doctor’s offices and hospitals for Covid-19 testing by breath samples.
With this, test result can be provided within three minutes and FDA said that test must be carried out under the supervision of a licensed health care provider.
According to the FDA authorities, the testing device is 91.2% accurate at identifying positive test samples of Covid-19.